<< Prev  1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 Next >>

Clinical Hold Lifted on Gilead HIV Therapy 05/16/2022

FDA Hits Lupin’s Novel Labs with 13-item 483 05/16/2022

FDA Rejects EUA for Fluvoxamine in Covid 05/16/2022

Nature Examines Potential Accelerated Approval Reforms 05/13/2022

HIV Tests Down Classified to 510(k) 05/13/2022

BridgeBio Pharma Sells Review Voucher for $110 Million 05/13/2022

Inspection Findings Sideline UCB Psoriasis Drug 05/13/2022

Scathing FDA-483 Hits Sun Pharma Over GMPs 05/13/2022

Lilly Once-weekly Diabetes Injection Approved 05/13/2022

New BD COR Molecular Diagnostic Platform Cleared 05/13/2022

<< Prev  1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20  Next >>